FULCRUM THERAPEUTICS, INC. (FULC) Operating cash flow 2018–2025
FULCRUM THERAPEUTICS, INC. (FULC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$60.1MFY2025 · since FY2018: -$22.6M → -$60.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$60.1M | -2608.1% |
| FY2024 | -$2.2M | +97.6% |
| FY2023 | -$91.0M | +6.3% |
| FY2022 | -$97.0M | -23.7% |
| FY2021 | -$78.5M | -46.3% |
| FY2020 | -$53.7M | -35.9% |
| FY2019 | -$39.5M | -75.0% |
| FY2018 | -$22.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FULC financial trends
FULC RevenueFULC Net incomeFULC Net marginFULC Gross profitFULC Gross marginFULC Operating incomeFULC Operating marginFULC Free cash flowFULC Capital expendituresFULC Return on equityFULC Stock buybacksFULC Dividends paidFULC Total assetsFULC Total liabilitiesFULC Shareholders’ equityFULC overview →